Easy, Simple, Fast
When it comes to treating acute myeloid leukemia (AML), time is of the essence. HLA typing at diagnosis, along with molecular markers and cytogenetics, are key to planning the best treatment course for patients with AML.
Free education activities
Browse our new education catalog to access on-demand, live, and podcast activities on key topics including AML, MDS and SCD treatment.
Explore the activities most relevant to your practice by using filters, such as disease specific, clinical topics, and continuing education credits.
Partnering to Save Lives
In addition to operating the Be The Match Registry, we also facilitate 6,400 transplants each year, conduct research, and support patients and clinicians. Find out all we do to partner with you to save lives.
The Latest HCT Research
Easily stay up-to-date on the latest research advances in hematopoietic cell transplantation (HCT) that is saving lives. Find summaries and references for recent publications.
Disease-Specific Indications and Outcomes
Find the latest references, outcomes, and referral timing guidelines by disease. Access patient-friendly handouts.
It only takes a minute to provide a better chance of a cure for acute myeloid leukemia (AML).Learn More
Novel cytogenetic-based risk scores predict HCT outcomes for patients with CLL
Are outcomes comparable by age in MAC vs. RIC transplantation for patients with AML in CR2?
Updated evidence-based guidelines for optimal selection of unrelated donors and cord blood units for HCT
About the Clinicians Section
This section of our health care professional website provides comprehensive information, research, and resources for health care professionals who care for patients before, during, and/or after hematopoietic cell transplant. The National Marrow Donor Program®(NMDP)/Be The Match® is a global leader in facilitating bone marrow and umbilical cord blood transplants to save the lives of patients with leukemia, lymphoma, genetic disorders, and other diseases, and conducts research through our research program, CIBMTR® (Center for International Blood and Marrow Transplant Research).
New clinician support in México
Since 2017, Be The Match® México
has been helping to save more lives through cellular therapy by improving donor
availability and removing barriers to transplant for patients of Latino
descent. Find out more about
how our subsidiary can help you facilitate transplants, conduct research, and provide
patient support in México.